3 results
hivaids infections prevention treatment antibiogram candida candidiasis esophageal hhv8 kaposisarcoma mucosal sensitivities spectrum
Spectrum of activity for systemic antifungal agents Antifungals: 5FC, flucytosine; AMB, amphotericin B; ANI, anidulafungin; CAS, caspofungin;
agents Antifungals ... fluconazole; ISA ... #antibiogram #management ... #pharmacology # ... spectrum #coverage
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days) Preferred
IDSA Recommendations ... Note: Systemic antifungals ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
IDSA Recommendations ... , Multicentric Castleman ... #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
No results found for "Drawer ligament management pharmacology idsa opportunistic coverage antifungal castlemans"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Drawer #ligament #management #pharmacology #idsa #opportunistic #coverage #antifungal #castlemans